Document is current

Any future updates will be listed below

PEGylated Liposomal Formulation of Alectinib Against Non-Small Cell Lung Cancer: Optimization, Characterization, Stability Assessment, In Vitro Cytotoxicity in A549 Cells and in Vivo Efficacy in C57BL/6 Mice

Crossref DOI link: https://doi.org/10.1007/s12247-025-10098-1

Published Online: 2025-09-26

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark